Stay updated on Preventing GvHD in Allo ApoGraft SCT - Clinical Trial

Sign up to get notified when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the site; no user-visible content or data changes are indicated in the screenshot.
    Difference
    0.1%
    Check dated 2026-03-18T17:49:46.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision history adds Revision: v3.4.3 and removes Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T15:53:48.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history, and the older funding notice and revision v3.4.1 were removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:23:32.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    A site-wide notice regarding government funding was added and the revision history shows a new revision v3.4.1, with the previous v3.4.0 entry removed.
    Difference
    0.8%
    Check dated 2026-02-04T01:18:01.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The record history page now shows additions in green and deletions in red, adds a Show glossary option, and updates the revision label to v3.4.0 while removing the prior No FEAR Act data note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-27T23:18:16.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The history adds revision v3.3.4, replacing v3.3.3. No study details or outcomes appear to be affected.
    Difference
    0.1%
    Check dated 2026-01-13T19:23:15.000Z thumbnail image

Stay in the know with updates to Preventing GvHD in Allo ApoGraft SCT - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Preventing GvHD in Allo ApoGraft SCT - Clinical Trial page.